R&D Go north: Life sciences excellence shines bright in Sweden Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.
R&D Purespring on nephrology & gene therapy in kidney disease Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.
R&D Sponsored What European Commission marketing authorisation of a teripa... Biosimilars can help support broader patient access while contributing to the long-term sustainability of healthcare systems.
R&D Why critical-care injectables are among the hardest medicine... When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl
R&D The future of Oxford: Science, technology, and collaboration In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
